The United States is expected to authorize the Pfizer-BioNTech Covid-19 vaccine for children age 12 and up by early next week, US media reported Monday.
The United States is expected to authorize the Pfizer-BioNTech Covid-19 vaccine for children age 12 and up by early next week, US media reported Monday.